160 related articles for article (PubMed ID: 22290601)
21. Application of silicon sensor technologies to tumor tissue in vitro: detection of metabolic correlates of chemosensitivity.
Mestres-Ventura P; Morguet A; Schofer A; Laue M; Schmidt W
Methods Mol Med; 2005; 111():109-25. PubMed ID: 15911976
[TBL] [Abstract][Full Text] [Related]
22. In vitro chemosensitivity in breast cancer using ATP-tumor chemosensitivity assay.
Qi CJ; Ning YL; Zhu YL; Min HY; Ye H; Qian KQ
Arch Pharm Res; 2009 Dec; 32(12):1737-42. PubMed ID: 20162402
[TBL] [Abstract][Full Text] [Related]
23. Drug Discovery Testing Compounds in Patient Samples by Automated Flow Cytometry.
Hernández P; Gorrochategui J; Primo D; Robles A; Rojas JL; Espinosa AB; Gómez C; Martínez-López J; Bennett TA; Ballesteros J
SLAS Technol; 2017 Jun; 22(3):325-337. PubMed ID: 28340541
[TBL] [Abstract][Full Text] [Related]
24. Heterogeneity of chemosensitivity in human breast carcinoma: use of an adenosine triphosphate (ATP) chemiluminescence assay.
Hunter EM; Sutherland LA; Cree IA; Dewar JA; Preece PE; Wood RA; Linder D; Andreotti PE
Eur J Surg Oncol; 1993 Jun; 19(3):242-9. PubMed ID: 8314382
[TBL] [Abstract][Full Text] [Related]
25. Toward Personalized Cancer Treatment: From Diagnostics to Therapy Monitoring in Miniaturized Electrohydrodynamic Systems.
Khondakar KR; Dey S; Wuethrich A; Sina AA; Trau M
Acc Chem Res; 2019 Aug; 52(8):2113-2123. PubMed ID: 31293158
[TBL] [Abstract][Full Text] [Related]
26. 3D Culture as a Clinically Relevant Model for Personalized Medicine.
Fong ELS; Toh TB; Yu H; Chow EK
SLAS Technol; 2017 Jun; 22(3):245-253. PubMed ID: 28277923
[TBL] [Abstract][Full Text] [Related]
27. [Chemosensitivity test of breast cancer].
Oura S; Tanino H; Naito Y
Nihon Rinsho; 2000 Apr; 58 Suppl():581-6. PubMed ID: 11026054
[No Abstract] [Full Text] [Related]
28. Patient-derived explants (PDEs) as a powerful preclinical platform for anti-cancer drug and biomarker discovery.
Powley IR; Patel M; Miles G; Pringle H; Howells L; Thomas A; Kettleborough C; Bryans J; Hammonds T; MacFarlane M; Pritchard C
Br J Cancer; 2020 Mar; 122(6):735-744. PubMed ID: 31894140
[TBL] [Abstract][Full Text] [Related]
29. Adapting a drug screening platform to discover associations of molecular targeted radiosensitizers with genomic biomarkers.
Liu Q; Wang M; Kern AM; Khaled S; Han J; Yeap BY; Hong TS; Settleman J; Benes CH; Held KD; Efstathiou JA; Willers H
Mol Cancer Res; 2015 Apr; 13(4):713-20. PubMed ID: 25667133
[TBL] [Abstract][Full Text] [Related]
30. Characterization of ascites-derived tumor cells from an endometrial cancer patient.
Li X; Zhu D; Li N; Yang H; Zhao Z; Li M
Cancer Sci; 2017 Dec; 108(12):2352-2357. PubMed ID: 28945304
[TBL] [Abstract][Full Text] [Related]
31. In vitro chemosensitivity testing of primary and recurrent breast carcinomas and its clinical significance.
Li Z; Song H; He W; Tian Y; Huang T
J Huazhong Univ Sci Technolog Med Sci; 2008 Dec; 28(6):683-7. PubMed ID: 19107367
[TBL] [Abstract][Full Text] [Related]
32. [Chips instead of mice: cells on bioelectronic sensor-chips as an alternative to animal experiments].
Otto AM; Brischwein M; Motrescu E; Cabala E; Grothe H; Stepper C; Wolf B
ALTEX; 2004; 21 Suppl 3():70-6. PubMed ID: 15057411
[TBL] [Abstract][Full Text] [Related]
33. Novel ex vivo ovarian cancer tissue explant assay for prediction of chemosensitivity and response to novel therapeutics.
Ricciardelli C; Lokman NA; Sabit I; Gunasegaran K; Bonner WM; Pyragius CE; Macpherson AM; Oehler MK
Cancer Lett; 2018 May; 421():51-58. PubMed ID: 29425684
[TBL] [Abstract][Full Text] [Related]
34. [Collagen gel droplet-embedded culture drug sensitivity test in human breast cancer].
Yamamoto Y; Watanabe Y; Ishida N; Hidaka T; Sugishita H; Yoshida M; Yukumi S; Sato K; Nakagawa H; Horiuchi A; Kawachi K
Gan To Kagaku Ryoho; 2008 May; 35(5):793-6. PubMed ID: 18487915
[TBL] [Abstract][Full Text] [Related]
35. Precision Medicine and Targeted Therapies in Breast Cancer.
Greenwalt I; Zaza N; Das S; Li BD
Surg Oncol Clin N Am; 2020 Jan; 29(1):51-62. PubMed ID: 31757313
[TBL] [Abstract][Full Text] [Related]
36. Precision Cancer Medicine in the Acoustic Dispensing Era: Ex Vivo Primary Cell Drug Sensitivity Testing.
Kulesskiy E; Saarela J; Turunen L; Wennerberg K
J Lab Autom; 2016 Feb; 21(1):27-36. PubMed ID: 26721820
[TBL] [Abstract][Full Text] [Related]
37. Using Peptide Aptamer Targeted Polymers as a Model Nanomedicine for Investigating Drug Distribution in Cancer Nanotheranostics.
Zhao Y; Houston ZH; Simpson JD; Chen L; Fletcher NL; Fuchs AV; Blakey I; Thurecht KJ
Mol Pharm; 2017 Oct; 14(10):3539-3549. PubMed ID: 28880092
[TBL] [Abstract][Full Text] [Related]
38. Spheroid-based 3D Cell Cultures Enable Personalized Therapy Testing and Drug Discovery in Head and Neck Cancer.
Hagemann J; Jacobi C; Hahn M; Schmid V; Welz C; Schwenk-Zieger S; Stauber R; Baumeister P; Becker S
Anticancer Res; 2017 May; 37(5):2201-2210. PubMed ID: 28476783
[TBL] [Abstract][Full Text] [Related]
39. Measuring Real-time Drug Response in Organotypic Tumor Tissue Slices.
Nishida-Aoki N; Bondesson AJ; Gujral TS
J Vis Exp; 2020 May; (159):. PubMed ID: 32420994
[TBL] [Abstract][Full Text] [Related]
40. Point: chemosensitivity assays have a role in the management of recurrent ovarian cancer.
Schink JC; Copeland LJ
J Natl Compr Canc Netw; 2011 Jan; 9(1):115-20. PubMed ID: 21233247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
